Axsome Therapeutics (AXSM) Operating Leases (2020 - 2026)
Axsome Therapeutics recorded quarterly Operating Leases of $22.4 million in Q1 2026, down 3.44% quarter-over-quarter from $23.2 million in Q4 2025, and down 6.36% year-over-year from $23.9 million in Q1 2025.
Axsome Therapeutics' Operating Leases history runs 6 years deep, the most recent figure standing at $22.4 million for Q1 2026.
- In Q1 2026, Operating Leases fell 6.36% year-over-year to $22.4 million; the TTM figure through Mar 2026 stood at $22.4 million (down 6.36% YoY), while the FY2025 annual figure was $23.2 million, up 283.43% from the prior year.
- Operating Leases came in at $22.4 million for Q1 2026 at Axsome Therapeutics, down from $23.2 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $23.9 million in Q1 2025 to a low of $6.0 million in Q4 2024.
- A 4-year average of $13.7 million and a median of $7.6 million in 2023 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases fell 16.27% in 2024 and jumped 283.43% in 2025, its largest moves.
- Axsome Therapeutics' Operating Leases stood at $7.0 million in 2023, then dropped by 14.06% to $6.0 million in 2024, then surged by 283.43% to $23.2 million in 2025, then declined by 3.44% to $22.4 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $22.4 million, $23.2 million, and $23.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.39 Mn |
| Dec 31, 2025 | 23.18 Mn |
| Sep 30, 2025 | 23.04 Mn |
| Jun 30, 2025 | 23.62 Mn |
| Mar 31, 2025 | 23.91 Mn |
| Dec 31, 2024 | 6.05 Mn |
| Sep 30, 2024 | 6.44 Mn |
| Jun 30, 2024 | 6.83 Mn |
| Mar 31, 2024 | 7.26 Mn |
| Dec 31, 2023 | 7.04 Mn |
| Sep 30, 2023 | 7.69 Mn |
| Jun 30, 2023 | 7.54 Mn |
| Jun 30, 2021 | 81,863.00 |
| Mar 31, 2021 | 329,916.00 |
| Dec 31, 2020 | 581,708.00 |